Conference Presentation

What's New at XXII A new blueprint and 180-day workplan ● Embracing our roots in plant-based, life science biotechnology Exploring global expansion in our tobacco and hemp/cannabis franchises Re-focusing on our disruptive, proprietary IP creation ● ● ● ● Focused on reduced nicotine tobacco plus new tobacco opportunities Enhancing cannabis franchise Looking to serve broader end markets across the life science, CPG (food, beverage, nutrition, personal care), recreational cannabis, and pharmaceutical space Identifying a third franchise specifically serving life science markets LO 5

View entire presentation